6291 - 6300 of 8825 Results
Title
Year
-
OPENTitle: Mapping dopaminergic projections in the human brain with resting-state fMRIJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.71846Best OA location URL: https://doi.org/10.7554/elife.71846Citation Count: 41
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 56
-
OPENTitle: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 6Issue #: 1Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000521232Best OA location URL: https://www.karger.com/Article/Pdf/521232Citation Count: 14
- Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy2022OPENTitle: Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2113489119Best OA location URL: https://escholarship.org/uc/item/3cf4v001Citation Count: 82
-
OPENTitle: One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain TissueJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 3Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14030599Best OA location URL: https://www.mdpi.com/2072-6643/14/3/599/pdf?version=1643524082Citation Count: 29
-
OPENTitle: Activation mechanism of PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 602Issue #: 7896Start Page: 328End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-021-04340-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8828467Citation Count: 190
-
OPENTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://www.nature.com/articles/s41593-021-00999-y.pdfCitation Count: 589
-
OPENTitle: Minimalist approaches to cancer tissue-of-origin classification by DNA methylationJournal Name: Modern PathologyPublisher: Elsevier BVVol: 33Issue #: 10Start Page: 1874End Page: 1888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41379-020-0547-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8808378Citation Count: 38
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 24End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 15
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page: e376End Page: e389Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 128